Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: An independent

Xian Liu1, Zhanwei Fan2, Tianshu Zhao3

  • 1Department of Cardiology, The Fourth Clinical Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.

Experimental Gerontology
|November 4, 2015
PubMed
Abstract

Insights

Circulating microRNAs (miRNAs) miR-1, miR-208, and miR-499 are elevated in acute myocardial infarction (AMI) patients. Cardiac-specific miR-208 and miR-499 show greater reliability as biomarkers for AMI prediction.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background:

  • Circulating muscle-enriched miR-1 and cardiac-specific miR-208/miR-499 may be released from necrotic myocardium during acute myocardial infarction (AMI).
  • Investigating the predictive value of these miRNAs in AMI is crucial for early diagnosis and management.

Purpose of the Study:

  • To evaluate the predictive potential of plasma miR-1, miR-208, and miR-499 as biomarkers for acute myocardial infarction (AMI).

Main Methods:

  • Plasma samples were collected from 70 AMI patients and 72 healthy controls.
  • MicroRNA expression levels were quantified using qRT-PCR.
  • Statistical analyses included Student's t test, χ(2) test, ROC curve analysis, and a meta-analysis of existing studies.

Main Results:

  • Plasma levels of miR-1, miR-208, and miR-499 were significantly higher in AMI patients compared to controls.
  • ROC analysis indicated potential biomarker utility with AUC values of 0.81 (miR-1), 0.72 (miR-208), and 0.88 (miR-499).
  • Meta-analysis revealed pooled sensitivity, specificity, and AUC values for miR-1, miR-208, and miR-499, confirming their diagnostic accuracy.

Conclusions:

  • Plasma miR-1, miR-208, and miR-499 demonstrate significant predictive value in acute myocardial infarction (AMI).
  • Cardiac-specific miR-208 and miR-499 are suggested to be more reliable biomarkers for AMI screening and prediction compared to miR-1.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
746
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
426